TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
RARE

Ultragenyx

Healthcare · Biotechnology

14.50$ +12.6% vs. previous close Closing price · As of: Sep 17, 2026

Filings

Filings

Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Ultragenyx (RARE) with date, type and a link to the original document.

Filings RARE
Date Type Filing Original
09/15/2026 Insider sale notice Form 144 filed with the SEC View document ↗
08/03/2026 Insider sale notice Form 144 filed with the SEC View document ↗

Showing the 100 most recent filings of the selected type.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?